Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
24,771,073
-
Share change
-
+1,358,289
-
Total reported value
-
$395,072,000
-
Put/Call ratio
-
83%
-
Price per share
-
$15.95
-
Number of holders
-
80
-
Value change
-
+$18,686,633
-
Number of buys
-
42
-
Number of sells
-
27
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2021
As of 31 Dec 2021 Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,771,073 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, RiverVest Venture Management LLC, Rock Springs Capital Management LP, AXA S.A., VANGUARD GROUP INC, BlackRock Inc., and FRANKLIN RESOURCES INC.
This table shows 81 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.